Effective March 25, 2013, Mr. Kenneth Hoberman was appointed as the Chief Operating Officer of Stemline Therapeutics, Inc. Kenneth Hoberman, age 48, has served as Stemline's Vice President of Operations since March 2012. From 2004 to 2012, Mr. Hoberman was Vice President of Corporate and Business Development of Keryx Biopharmaceuticals, Inc.